Organophosphorus compounds
Matrix Scientific 5-METHYL-2-PYRIDIN-3-YLM 500MG
5-METHYL-2-PYRIDIN-3-YLMETHYL-2H-PYRAZOL-3-YLAMINE 100mg CAS#957500-08-2 MFCD07186471 C10H12N4 MW:188.23
Medchemexpress LLC Gamitrinib TPP hexafluorophosphate | 1131626-47-5 | MFCD31715433 | 99.7% | 1,036.03 g/mol | C52H65F6N3O8P2 | 50 MG
Gamitrinib TPP hexafluorophosphate is a mitochondria-targeted HSP90 inhibitor used in preclinical research to selectively disrupt mitochondrial HSP90 function and impair tumor bioenergetics. The triphenylphosphonium (TPP) moiety directs the compound to the mitochondrial matrix, increasing mitochondrial accumulation and cytotoxic activity in cell and animal cancer models.
- Mitochondria-targeted HSP90 inhibitor
- Targets mitochondrial bioenergetics and induces cancer cell death
- Enhanced mitochondrial accumulation via triphenylphosphonium moiety
- Reported high chemical purity (≈99.7%)
- Provided as a solid for preclinical research use
Medchemexpress LLC Sodium tetradecyl sulfate (Tergitol 4) | 139-88-8 | 99.5% | C14H29NaO4S | 10 ML
Sodium tetradecyl sulfate (Tergitol 4) is a scleroembolic agent and apoptosis inducer. It is used for research on varicose veins and vascular malformation diseases.
- Induces endothelial activation and release of endothelial particles in HUVEC.
- Increases expression of activation markers CD54 and CD62e.
- Inhibits proliferation and induces apoptosis in mouse endothelial tumor (EOMA) cells.
Medchemexpress LLC Sodium tetradecyl sulfate (Tergitol 4) | 139-88-8 | MFCD00072416 | 99.5% | C14H29NaO4S | 100 ML
Sodium tetradecyl sulfate (Tergitol 4) is a novel scleroembolic agent and an apoptosis inducer. It is intended for research applications, specifically in the study of varicose veins and vascular malformation diseases.
- Novel scleroembolic agent
- Apoptosis inducer
- Used for research on varicose veins and vascular malformation diseases
- Induces endothelial activation and release of endothelial particles
- Inhibits proliferation and induces apoptosis in EOMA cells